SMYD2诱导的PGC1α甲基化促进胶质母细胞瘤干细胞的干性维持
该研究探讨SMYD2诱导的PGC1α甲基化及核输出对胶质母细胞瘤干细胞(GSCs)线粒体生物发生和干性维持的影响,通过免疫共沉淀、细胞分级分离、免疫荧光及颅内胶质瘤模型验证SMYD2/PGC1α/CRM1轴的作用,发现PGC1α K224甲基化促进CRM1结合并加速核输出,导致线粒体功能障碍并增强GSCs干性和放射抵抗,靶向该甲基化可提高放疗疗效并延长生存。
要点
- SMYD2催化PGC1α K224甲基化(K224me),促进GSCs干性特征。
- PGC1α K224me优先结合CRM1,加速PGC1α核输出及线粒体功能障碍。
- 靶向PGC1α甲基化可增强放疗疗效并延长患者生存。
核心结论
- 研究揭示SMYD2/PGC1α/CRM1轴调控GSCs线粒体功能与干性的新通路,靶向PGC1α和线粒体是治疗GBM的潜在策略。
研究设计与样本
- 研究采用免疫共沉淀、细胞分级分离、免疫荧光、耗氧率、ECAR及颅内胶质瘤模型验证SMYD2/PGC1α/CRM1轴对GSCs线粒体生物发生的影响。
主要发现
- PGC1α甲基化导致线粒体功能受损,从而维持GSCs干性并增强其放射抵抗。
- SMYD2驱动PGC1α K224甲基化(K224me),该修饰对促进GSCs干样特性至关重要。
- PGC1α K224me优先与CRM1结合,加速PGC1α核输出及后续功能障碍。
- 靶向PGC1α甲基化表现出显著的放疗疗效并延长患者生存。
关键数值与推荐
- SMYD2诱导PGC1α K224甲基化(K224me),该位点甲基化是促进GSCs干样特性的关键。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The high fatality rate of glioblastoma (GBM) is attributed to glioblastoma stem cells (GSCs), which exhibit heterogeneity and therapeutic resistance. Metabolic plasticity of mitochondria is the hallmark of GSCs. Targeting mitochondrial biogenesis of GSCs is crucial for improving clinical prognosis in GBM patients. METHODS: SMYD2-induced PGC1α methylation and followed nuclear export are confirmed by co-immunoprecipitation, cellular fractionation, and immunofluorescence. The effects of SMYD2/PGC1α/CRM1 axis on GSCs mitochondrial biogenesis are validated by oxygen consumption rate, ECAR, and intracranial glioma model. RESULTS: PGC1α methylation causes the disabled mitochondrial function to maintain the stemness, thereby enhancing the radio-resistance of GSCs. SMYD2 drives PGC1α K224 methylation (K224me), which is essential for promoting the stem-like characteristics of GSCs. PGC1α K224me is preferred binding with CRM1, accelerating PGC1α nuclear export and subsequent dysfunction. Targeting PGC1α methylation exhibits significant radiotherapeutic efficacy and prolongs patient survival. CONCLUSIONS: These findings unveil a novel regulatory pathway involving mitochondria that govern stemness in GSCs, thereby emphasizing promising therapeutic strategies targeting PGC1α and mitochondria for the treatment of GBM.
引用
- Li M, Zhang Z, He L, et al. SMYD2 induced PGC1α methylation promotes stemness maintenance of glioblastoma stem cells. Neuro Oncol. 2024. PMID: 38721826. doi:10.1093/neuonc/noae090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。